AXCAN PHARMA INC has a total of 38 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are LAURAS AS, INVIRSA INC and TONIX PHARMA HOLDINGS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | China | 5 | |
#3 | Canada | 4 | |
#4 | Australia | 2 | |
#5 | Brazil | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | Mexico | 2 | |
#9 | United States | 2 | |
#10 | Argentina | 1 | |
#11 | Czechia | 1 | |
#12 | Hong Kong | 1 | |
#13 | Hungary | 1 | |
#14 | Indonesia | 1 | |
#15 | Norway | 1 | |
#16 | New Zealand | 1 | |
#17 | Peru | 1 | |
#18 | Poland | 1 | |
#19 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Foods and drinks | |
#6 | Chemical engineering | |
#7 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Sugars | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Unspecified technologies | |
#8 | Separation | |
#9 | Natural saccharides |
# | Name | Total Patents |
---|---|---|
#1 | Sanso Giovanni | 10 |
#2 | Delaney Edward | 6 |
#3 | Rahman Mohammad | 5 |
#4 | Caswell Michael | 5 |
#5 | Ratziu Vlad | 4 |
#6 | Riviere Marc | 4 |
#7 | Dumoulin Yves | 4 |
#8 | Spenard Jean | 4 |
#9 | Sanso' Giovanni | 3 |
#10 | Tijssen Peter | 3 |
Publication | Filing date | Title |
---|---|---|
AU2010224587A1 | Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid | |
CA2690450A1 | Mesalamine suppository | |
WO2009109856A2 | Method for detecting infectious parvovirus in pharmaceutical preparations | |
US2009022793A1 | Mesalamine suppository | |
CA2419572A1 | High dosage protease formulation |